1. The gut microbiome and type 2 diabetes status in the Multiethnic Cohort
- Author
-
Johanna W. Lampe, Gertraud Maskarinec, Meredith A. J. Hullar, Bruce S. Kristal, Phyllis Raquinio, Adrian A. Franke, Loïc Le Marchand, Veronica Wendy Setiawan, Unhee Lim, Timothy W. Randolph, and Lynne R. Wilkens
- Subjects
Male ,endocrine system diseases ,Physiology ,Type 2 diabetes ,Pathology and Laboratory Medicine ,Cohort Studies ,Feces ,Endocrinology ,Medical Conditions ,RNA, Ribosomal, 16S ,Medicine and Health Sciences ,Multidisciplinary ,biology ,Organic Compounds ,Monosaccharides ,Genomics ,Middle Aged ,Metformin ,Type 2 Diabetes ,Bacterial Pathogens ,Actinobacteria ,Chemistry ,Medical Microbiology ,Cohort ,Physical Sciences ,Medicine ,Female ,Pathogens ,Research Article ,Escherichia ,Firmicutes ,Endocrine Disorders ,Science ,Carbohydrates ,Microbial Genomics ,Microbiology ,Prediabetic State ,Enterobacteriaceae ,Diabetes mellitus ,medicine ,Genetics ,Diabetes Mellitus ,Humans ,Microbiome ,Microbial Pathogens ,Glycemic ,Aged ,Clostridium ,Bacteria ,business.industry ,Lachnospiraceae ,Gut Bacteria ,Organic Chemistry ,Organisms ,Chemical Compounds ,nutritional and metabolic diseases ,Biology and Life Sciences ,biology.organism_classification ,medicine.disease ,Gastrointestinal Microbiome ,Cross-Sectional Studies ,Glucose ,Diabetes Mellitus, Type 2 ,Metabolic Disorders ,Synergistetes ,business - Abstract
Background The gut microbiome may play a role in inflammation associated with type 2 diabetes (T2D) development. This cross-sectional study examined its relation with glycemic status within a subset of the Multiethnic Cohort (MEC) and estimated the association of circulating bacterial endotoxin (measured as plasma lipopolysaccharide-binding protein (LBP)) with T2D, which may be mediated by C-reactive protein (CRP). Methods In 2013–16, cohort members from five ethnic groups completed clinic visits, questionnaires, and stool and blood collections. Participants with self-reported T2D and/or taking medication were considered T2D cases. Those with fasting glucose >125 and 100–125 mg/dL were classified as undiagnosed (UT2D) and pre-diabetes (PT2D) cases, respectively. We characterized the gut microbiome through 16S rRNA gene sequencing and measured plasma LBP and CRP by standard assays. Linear regression was applied to estimate associations of the gut microbiome community structure and LBP with T2D status adjusting for relevant confounders. Results Among 1,702 participants (59.9–77.4 years), 735 (43%) were normoglycemic (NG), 506 (30%) PT2D, 154 (9%) UT2D, and 307 (18%) T2D. The Shannon diversity index decreased (ptrend = 0.05), while endotoxin, measured as LBP, increased (ptrend = 0.0003) from NG to T2D. Of 10 phyla, Actinobacteria (ptrend = 0.007), Firmicutes (ptrend = 0.003), and Synergistetes (ptrend = 0.02) were inversely associated and Lentisphaerae (ptrend = 0.01) was positively associated with T2D status. Clostridium sensu stricto 1, Lachnospira, and Peptostreptococcaceae were less, while Escherichia-Shigella and Lachnospiraceae were more abundant among T2D patients, but the associations with Actinobacteria, Clostridium sensu stricto 1, and Escherichia-Shigella may be due metformin use. PT2D/UT2D values were closer to NG than T2D. No indication was detected that CRP mediated the association of LBP with T2D. Conclusions T2D but not PT2D/UT2D status was associated with lower abundance of SCFA-producing genera and a higher abundance of gram-negative endotoxin-producing bacteria suggesting that the gut microbiome may contribute to chronic systemic inflammation and T2D through bacterial translocation.
- Published
- 2020